(in millions $) | 30 Oct 2024 | 30 Jul 2024 | 1 May 2024 | 31 Jan 2024 |
---|---|---|---|---|
Current assets | ||||
Cash | ||||
Short term investments | ||||
Net receivables | $32.03 | $34.01 | $51.63 | $49.77 |
Inventory | $22.54 | $21.24 | $20.56 | $22.26 |
Total current assets | $271.31 | $288.81 | $332.9 | $434.03 |
Long term investments | ||||
Property, plant & equipment | $321.12 | $347.45 | $384.95 | $406.62 |
Goodwill & intangible assets | ||||
Total noncurrent assets | ||||
Total investments | ||||
Total assets | $1043.14 | $1086.29 | $1181.29 | $1316.06 |
Current liabilities | ||||
Accounts payable | $35 | $41.93 | $45.69 | $32.97 |
Deferred revenue | ||||
Short long term debt | ||||
Total current liabilities | $888.41 | $874.11 | $878.73 | $907.5 |
Long term debt | $209.59 | $218.61 | $222.78 | $235.07 |
Total noncurrent liabilities | ||||
Total debt | ||||
Total liabilities | $1160.8 | $1158.44 | $1180.36 | $1218.66 |
Shareholders' equity | ||||
Retained earnings | -$2015.36 | -$1957.63 | -$1860.65 | -$1763.26 |
Other shareholder equity | -$5.54 | -$12.34 | -$12.25 | -$10.7 |
Total shareholder equity |
(in millions $) | 31 Jan 2024 | 31 Jan 2023 | 31 Jan 2022 | 31 Jan 2021 |
---|---|---|---|---|
Current assets | ||||
Cash | $0.72 | |||
Short term investments | ||||
Net receivables | $49.77 | $117.91 | $87.46 | |
Inventory | $22.26 | $53.83 | $9.41 | |
Total current assets | $434.03 | $819.62 | $933.07 | $1.33 |
Long term investments | ||||
Property, plant & equipment | $406.62 | $501.29 | $426.42 | |
Goodwill & intangible assets | ||||
Total noncurrent assets | $239.8 | |||
Total investments | ||||
Total assets | $1316.06 | $1971.22 | $1981.06 | $241.12 |
Current liabilities | ||||
Accounts payable | $32.97 | $43.17 | $43.67 | |
Deferred revenue | ||||
Short long term debt | ||||
Total current liabilities | $907.5 | $1344.22 | $1135.04 | $1.48 |
Long term debt | $235.07 | $226.23 | ||
Total noncurrent liabilities | $234.64 | |||
Total debt | ||||
Total liabilities | $1218.66 | $1671.31 | $1250.91 | $236.12 |
Shareholders' equity | ||||
Retained earnings | -$1763.26 | -$1227.87 | -$720.71 | -$1.55 |
Other shareholder equity | -$10.7 | -$10.05 | ||
Total shareholder equity |
(in millions $) | 30 Oct 2024 | 30 Jul 2024 | 1 May 2024 | 31 Jan 2024 |
---|---|---|---|---|
Revenue | ||||
Total revenue | $193.9 | $196.28 | $197.1 | $246.38 |
Cost of revenue | ||||
Gross Profit | $27.04 | $4.59 | -$1.16 | -$4.54 |
Operating activities | ||||
Research & development | ||||
Selling, general & administrative | ||||
Total operating expenses | $69.16 | $83.55 | $84.15 | $65.98 |
Operating income | ||||
Income from continuing operations | ||||
EBIT | ||||
Income tax expense | $0.41 | $0.44 | -$0.11 | $0.63 |
Interest expense | -$15.13 | -$16.38 | -$14.5 | -$14.19 |
Net income | ||||
Net income | -$57.73 | -$96.97 | -$97.39 | -$81.11 |
Income (for common shares) |
(in millions $) | 31 Jan 2024 | 31 Jan 2023 | 31 Jan 2022 | 31 Jan 2021 |
---|---|---|---|---|
Revenue | ||||
Total revenue | $1253.32 | $1579.8 | $1194.26 | |
Cost of revenue | ||||
Gross Profit | $20.81 | $39.4 | $76.63 | |
Operating activities | ||||
Research & development | ||||
Selling, general & administrative | ||||
Total operating expenses | $355.11 | $418.5 | $281.19 | $1.6 |
Operating income | -$1.6 | |||
Income from continuing operations | ||||
EBIT | ||||
Income tax expense | $1.38 | $0.2 | $0.06 | |
Interest expense | -$35.13 | $5.7 | $8.48 | |
Net income | ||||
Net income | -$487.39 | -$555.2 | -$190.02 | -$1.55 |
Income (for common shares) |
(in millions $) | 30 Oct 2024 | 30 Jul 2024 | 1 May 2024 | 31 Jan 2024 |
---|---|---|---|---|
Net income | ||||
Operating activities | ||||
Depreciation | ||||
Business acquisitions & disposals | ||||
Stock-based compensation | ||||
Total cash flows from operations | ||||
Investing activities | ||||
Capital expenditures | ||||
Investments | ||||
Total cash flows from investing | $26.06 | $24.09 | $19.6 | $40.87 |
Financing activities | ||||
Dividends paid | ||||
Sale and purchase of stock | ||||
Net borrowings | ||||
Total cash flows from financing | -$52.96 | -$41.4 | -$24.31 | $300.95 |
Effect of exchange rate | -$1.27 | -$1.18 | -$1.03 | -$3.87 |
Change in cash and equivalents | -$143.99 | -$119.26 | -$79.53 | -$327.33 |
(in millions $) | 31 Jan 2024 | 31 Jan 2023 | 31 Jan 2022 | 31 Jan 2021 |
---|---|---|---|---|
Net income | -$1.55 | |||
Operating activities | ||||
Depreciation | ||||
Business acquisitions & disposals | ||||
Stock-based compensation | ||||
Total cash flows from operations | -$1.08 | |||
Investing activities | ||||
Capital expenditures | ||||
Investments | ||||
Total cash flows from investing | $40.87 | -$175.2 | -$38.67 | -$239.75 |
Financing activities | ||||
Dividends paid | ||||
Sale and purchase of stock | ||||
Net borrowings | ||||
Total cash flows from financing | $300.95 | $244.8 | $374.03 | $241.55 |
Effect of exchange rate | -$3.87 | -$5.4 | ||
Change in cash and equivalents | -$327.33 | -$166.5 | $461.85 | $0.72 |
Market cap | $1.26B |
---|---|
Enterprise value | N/A |
Shares outstanding | 697.81M |
Revenue | $833.67M |
---|---|
EBITDA | N/A |
EBIT | N/A |
Net Income | -$333.21M |
Revenue Q/Q | N/A |
Revenue Y/Y | N/A |
P/E ratio | -3.79 |
---|---|
EV/Sales | N/A |
EV/EBITDA | N/A |
EV/EBIT | N/A |
P/S ratio | 1.52 |
P/B ratio | N/A |
Book/Share | N/A |
Cash/Share | N/A |
EPS | -$0.48 |
---|---|
ROA | -28.81% |
ROE | N/A |
Debt/Equity | N/A |
---|---|
Net debt/EBITDA | N/A |
Current ratio | 0.31 |
Quick ratio | 0.28 |